CMAC will be attending this workshop, which focuses on how Artificial Intelligence (AI) is transforming drug development and regulatory processes across the pharmaceutical industry.

The programme will explore cutting-edge applications of modeling and AI throughout the drug development lifecycle, with a particular emphasis on complex generics. Through presentations, panel discussions, and interactive sessions, attendees will examine how AI is being integrated into regulatory frameworks to streamline workflows, accelerate development timelines, and advance quantitative medicine approaches.